Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office

Generated: September 23, 2019

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: dalfampridine

  Try a free trial

See Plans and Pricing

« Back to Dashboard

dalfampridine Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Alkem Labs Ltd dalfampridine 206765 10MG TABLET, EXTENDED RELEASE;ORAL
Sun Pharm Inds Ltd dalfampridine 208292 10MG TABLET, EXTENDED RELEASE;ORAL
Roxane dalfampridine 206646 10MG TABLET, EXTENDED RELEASE;ORAL
Accord Hlthcare Inc dalfampridine 206863 10MG TABLET, EXTENDED RELEASE;ORAL
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.